Allison Hagerman
Chief Technology OfficerMs. Allison Hagerman, P.Eng., PMP, MBT, serves as Chief Technology Officer since 2026 and was Vice President of Product Development at Oncolytics Biotech Inc. since October 2018 until 2026. She is a Professional Engineer focused on biotechnology, Ms. Hagerman joined Oncolytics in 2010 and has been integral to the progress of its product development program ever since. She was the Director, Manufacturing and Engineering since 2013 until 2017 and Project Manager since 2010 until 2013, during which time she led the process performance qualification for pelareorep drug substance. Ms. Hagerman is a Professional Engineer (P.Eng., APEGA) and Project Management Professional (PMP, PMI). She holds a Master of Biomedical Technology (MBT) degree from the University of Calgary and B.Sc. degrees in both Chemical Engineering and Biological Sciences.
Positions
- Company NameOncolytics Biotech Inc.Stock CodeONCYPositionChief Technology OfficerColleagues
- JKJared KellyCEO & Director
- WFWayne F. PisanoChairman of the Board
- KJKirk J. LookChief Financial Officer
- TCThomas C. HeinemanChief Medical Officer
- JMJohn McAdoryChief Operating Officer
- AFAngela Frances HolthamIndependent Director
- DMDeborah M. BrownIndependent Director
- JMJonathan M. N. RigbyIndependent Director
